Testing effectiveness (Phase 2)Study completedNCT00446446
What this trial is testing
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
Who this might be right for
CancerCarcinomaHead and Neck Cancer+6 more
Amgen 52
Showing 20 of 0 results